Fludarabine as second-line therapy for B cell chronic lymphocytic leukaemia: a technology assessment
Open accessThe DOI matches its Crossref record.
Abstract
A peer reviewer notes that use of soluble CD23 levels in the UK is rare and that much greater emphasis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Hobart, J., & Cano, S. (2009) · Health Technology Assessment · doi:10.3310/hta13120 · Cited by 621
Evaluation of diagnostic tests when there is no gold standard. A review of methods
Rutjes, A., Reitsma, J., Coomarasamy, A., Khan, K., & Bossuyt, P. (2007) · Health Technology Assessment · doi:10.3310/hta11500 · Cited by 524
Moher, D., Pham, B., Lawson, M., & Klassen, T. (2003) · Health Technology Assessment · doi:10.3310/hta7410 · Cited by 500
Jones, J., Shepherd, J., Baxter, L., Gospodarevskaya, E., Hartwell, D., Harris, P., & Price, A. (2009) · Health Technology Assessment · doi:10.3310/hta13350 · Cited by 357
Taylor, R. S., Van Buyten, J., & Buchser, E. (2006) · European Journal of Pain · doi:10.1016/j.ejpain.2005.02.004 · Cited by 276
Metadata
- Authors
- Hyde, C., Wake, B., Bryan, S., Barton, P., Fry-Smith, A., Davenport, C., & Song, F.
- Venue
- Health Technology Assessment
- Published
- 2002
- Volume
- 6
- Issue
- 2
- Pages
- 1-89
- ISSN
- 1366-5278 (ISSN-L)
- 2046-4924
- OpenAlex
- W1993553202
- Cited by
- 90
- References
- 0
- FWCI
- 2.33
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fludarabine as second-line therapy for B cell chronic lymphocytic leukaemia: a technology assessment. https://app.cochat.ai/papers/10.3310/hta6020
- The paper
- Hyde, C., Wake, B., Bryan, S., Barton, P., Fry-Smith, A., Davenport, C., & Song, F. (2002). Fludarabine as second-line therapy for B cell chronic lymphocytic leukaemia: a technology assessment. Health Technology Assessment. https://doi.org/10.3310/hta6020
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.